NCT05052008View on ClinicalTrials.gov

Management of Migraine Using Enerumab and Traditional Therapy at the Time of COVID-19

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

August 15, 2020

Primary Completion Date

August 10, 2021

Study Completion Date

September 10, 2021

Conditions
Migraine Disorders
Interventions
DRUG

Erenumab

Erenumab is monoclonal antibody used for management of migraine

Trial Locations (1)

63111

Marwa Kamal Ahmed Tolba, Al Fayyum

All Listed Sponsors
lead

Fayoum University

OTHER

NCT05052008 - Management of Migraine Using Enerumab and Traditional Therapy at the Time of COVID-19 | Biotech Hunter | Biotech Hunter